Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $222.35 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $37.88 | 3 | $0 (2019) |
| PFIZER INC. | $36.16 | 3 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $31.10 | 2 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.86 | 3 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $21.74 | 2 | $0 (2019) |
| Allergan Inc. | $16.23 | 1 | $0 (2018) |
| Amgen Inc. | $15.56 | 1 | $0 (2018) |
| SANOFI PASTEUR INC. | $15.00 | 1 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $12.98 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $10.84 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $42.86 | 3 | SANOFI PASTEUR INC. ($15.00) |
| 2019 | $91.90 | 7 | Janssen Pharmaceuticals, Inc ($27.09) |
| 2018 | $65.96 | 6 | Allergan Inc. ($16.23) |
| 2017 | $21.63 | 2 | AstraZeneca Pharmaceuticals LP ($10.84) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/04/2020 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, ADACEL | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Vaccines | ||||||
| 03/03/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/17/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/13/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/12/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 03/05/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/14/2019 | Merck Sharp & Dohme Corporation | ROTATEQ (Biological), PNEUMOVAX 23, VAQTA | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: VACCINE | ||||||
| 02/05/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/18/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Endocrinology | ||||||
| 12/12/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Central Nervous System (CNS) | ||||||
| 12/12/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $0.12 | General |
| Category: Central Nervous System (CNS) | ||||||
| 10/16/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/02/2018 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: VACCINE | ||||||
| 05/29/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/13/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 258 | 317 | $64,409 | $27,987 |
| 2022 | 7 | 297 | 347 | $59,677 | $29,531 |
| 2021 | 5 | 292 | 464 | $107,593 | $33,711 |
| 2020 | 6 | 382 | 549 | $124,176 | $32,949 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 82 | 82 | $23,206 | $10,975 | 47.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 151 | $23,728 | $9,871 | 41.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 42 | $11,298 | $4,289 | 38.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $4,572 | $2,062 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 15 | $1,125 | $716.43 | 63.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 15 | 15 | $480.00 | $73.92 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 167 | $22,640 | $10,646 | 47.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 66 | 66 | $17,170 | $9,073 | 52.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 42 | $8,008 | $4,571 | 57.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 16 | 16 | $6,096 | $2,834 | 46.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,026 | $1,796 | 44.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 13 | $873.00 | $464.84 | 53.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 27 | 27 | $864.00 | $145.53 | 16.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 141 | 306 | $61,758 | $18,691 | 30.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 86 | 86 | $32,400 | $10,772 | 33.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 24 | 29 | $8,416 | $2,514 | 29.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Facility | 2021 | 12 | 12 | $2,954 | $1,548 | 52.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 29 | 31 | $2,065 | $185.02 | 9.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 195 | 356 | $68,133 | $17,456 | 25.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2020 | 93 | 93 | $33,378 | $10,181 | 30.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2020 | 18 | 18 | $9,730 | $2,925 | 30.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 17 | 18 | $4,965 | $1,236 | 24.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 20 | 20 | $2,442 | $746.67 | 30.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 15 | $3,681 | $233.77 | 6.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 28 | 29 | $1,847 | $170.95 | 9.3% |
About Dr. Rahil Shaikh, M.D
Dr. Rahil Shaikh, M.D is a Family Medicine healthcare provider based in Lincolnwood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2012. The National Provider Identifier (NPI) number assigned to this provider is 1538415518.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rahil Shaikh, M.D has received a total of $222.35 in payments from pharmaceutical and medical device companies, with $42.86 received in 2020. These payments were reported across 18 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($222.35).
As a Medicare-enrolled provider, Shaikh has provided services to 1,229 Medicare beneficiaries, totaling 1,677 services with total Medicare billing of $124,177. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Lincolnwood, IL
- Active Since 07/27/2012
- Last Updated 10/06/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1538415518
Products in Payments
- CHANTIX (Drug) $36.16
- ENTRESTO (Drug) $31.10
- XARELTO (Drug) $27.09
- LINZESS (Drug) $16.23
- Prolia (Biological) $15.56
- FLUZONE HIGH-DOSE (Biological) $15.00
- TRINTELLIX (Drug) $13.12
- PRALUENT (Biological) $12.98
- Trintellix (Drug) $11.74
- ROTATEQ (Biological) $11.13
- BEVESPI AEROSPHERE (Drug) $10.84
- INVOKANA (Drug) $10.79
- PNEUMOVAX 23 (Biological) $10.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lincolnwood
Robert Wolfe, M.d, M.D
Family Medicine — Payments: $4,506
Dr. Frederic Ettner, M.d, M.D
Family Medicine — Payments: $3,929
Juwaria Siddiqui, M.d, M.D
Family Medicine — Payments: $1,195
Manoj Mathew, M.d, M.D
Family Medicine — Payments: $801.58
Solomon Yigazu, Md, MD
Family Medicine — Payments: $682.41
Dr. Ana Gavrilovici, M.d, M.D
Family Medicine — Payments: $618.46